Psi Advisors, LLC Eli Lilly & CO Transaction History

Psi Advisors, LLC

$338 Million
Q3 2024

A detailed history of Psi Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Psi Advisors, LLC holds 2,908 shares of LLY stock, worth $2.31 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

2,908

Previous 2,895 0.45%

Holding current value

$2.31 Million

Previous $2.62 Million 1.72%

% of portfolio

0.76%

Previous 0.84%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$772.14 - $960.02 $10,037 - $12,480	13 Added 0.45%	2,908 $2.58 Million
Q2 2024 Jul 23, 2024	SELL	$724.87 - $909.04 $9,423 - $11,817	-13 Reduced 0.45%	2,895 $2.62 Million
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $31,978 - $42,783	-54 Reduced 1.82%	2,908 $2.26 Million
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $139,175 - $164,069	265 Added 9.83%	2,962 $1.73 Million
Q3 2023 Oct 13, 2023	BUY	$434.7 - $599.3 $23,908 - $32,961	55 Added 2.08%	2,697 $1.45 Million
Q2 2023 Jul 21, 2023	BUY	$350.74 - $468.98 $18,589 - $24,855	53 Added 2.05%	2,642 $1.24 Million
Q1 2023 Apr 25, 2023	BUY	$310.63 - $364.82 $237,942 - $279,452	766 Added 42.02%	2,589 $889,000
Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $5,144 - $5,994	16 Added 0.89%	1,823 $0
Q3 2022 Oct 20, 2022	BUY	$296.48 - $337.87 $2,964 - $3,378	10 Added 0.56%	1,807 $584,000
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $68,288 - $80,181	-245 Reduced 12.0%	1,797 $583,000
Q1 2022 Apr 20, 2022	BUY	$234.69 - $291.66 $26,285 - $32,665	112 Added 5.8%	2,042 $585,000
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $50,591 - $62,784	-225 Reduced 10.44%	1,930 $533,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $80,884 - $99,539	365 Added 20.39%	2,155 $498,000
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $306,935 - $397,018	-1,700 Reduced 48.71%	1,790 $410,000
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $100,070 - $129,546	-609 Reduced 14.86%	3,490 $652,000
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $12,002 - $15,881	-92 Reduced 2.2%	4,099 $692,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $170,784 - $197,543	1,168 Added 38.64%	4,191 $620,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $186,908 - $231,339	1,570 Added 108.05%	3,023 $419,000
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $155,354 - $192,420	1,453 New	1,453 $190,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Psi Advisors, LLC with notifications on news.

Account